explore -WSS

explore

author：comprehensive 2025-10-01 14:15:51 - browse：81

Ron Wyden, left, and Mike Crapo, right. -- health policy coverage from STAT — Sens. Ron Wyden and Mike Crapo passed a new slate of pharmacy benefit manager reforms through the Finance Committee. Kevin Dietsch/Getty Images

WASHINGTON — A prominent Senate panel on Wednesday passed a new package of health policy reforms that would rein in certain pharmacy middlemen practices and ensure Medicare patients aren’t paying more than insurers do for medications.

The package passed the committee 26-0 with no amendments added. Sen. Ron Johnson (R-Wis.) didn’t vote.

The package, crafted by Senate Finance Chair Ron Wyden (D-Ore.) and Mike Crapo (R-Idaho) also includes policy on a broad range of health care priorities, including substance abuse and mental health care and extensions to provider pay. The pharmacy benefit manager regulations build on a separate package of PBM regulations that the panel passed in July.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： How to save PrEP access — and even expand it
Next article： Why the quest to eradicate polio has stumbled

hotspot

WSS

Abortion pill Supreme Court ruling could impact entire drug industry

Patients, doctors press FTC to beef up hospital merger scrutiny

Washington mulls new rules to avert another Change Healthcare

FDA's naming rule on biosimilars has undermined competition

The unintended consequences of overturning Roe v. Wade

Oprah kicked off a national conversation on obesity. Let's have it

entertainment

explore

focus

Affirmative action in medical school literally saved lives

Readout Newsletter: Merck, Vertex, and Viking updates

Hepatitis C has a cure — but many Americans still lack access to it

Grad students accuse University of California of wage theft

Walensky prepares to leave CDC — and Congress — behind

Covid vaccine financial winners and losers, from Pfizer to Novavax

Hepatitis C has a cure — but many Americans still lack access to it

FDA's naming rule on biosimilars has undermined competition

Apple is now the first public company to be valued at $3 trillion

Decaf coffee targeted by food safety group under obscure FDA rule

explore

Transgender sports debate: Physicians say bans are health issue

Decaf coffee targeted by food safety group under obscure FDA rule

Abortion pill Supreme Court ruling could impact entire drug industry

FDA panel to weigh safety of artificial wombs for preterm births

Assistant physicians can help address the primary care shortage

What happened to the House vote on health price transparency?

focus

hotspot

explore

entertainment